Data / Form D filings / Mitera Biosciences Inc.
Mitera Biosciences Inc.: Form D filings
Mitera Biosciences Inc., a biotechnology company in Bellevue, WA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on May 6, 2026, reports $1.1 million sold of a $3 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3120 139th Avenue Southeast Suite 500, Bellevue, WA, 98005
- Phone
- (425) 818-5036
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2022224
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | New notice | $3,000,000 | $1,100,000 | $1,900,000 | 2 | Apr 21, 2026 | sec.gov |
| Dec 22, 2025 | Amendment | $2,000,000 | $1,745,000 | $255,000 | 6 | Apr 24, 2024 | sec.gov |
| May 9, 2024 | New notice | $1,500,000 | $600,000 | $900,000 | 2 | Apr 24, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Chow | Executive Officer, Director, Promoter |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mitera Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.